Moderna Promises VACCINES for CANCER and Heart Disease

Moderna Promises VACCINES for CANCER and Heart Disease

( – According to the CDC, the two leading causes of death in the United States are heart disease and cancer, totaling over 1,300,000 people in 2021. While there are numerous theories and experts on these diseases trying to pinpoint how to fight them, one major vaccine firm is hopeful it can join the battle against death. According to a new, exclusive report, the head of Moderna believes the company will be able to produce vaccines for cancer, heart disease, and autoimmune diseases by 2030.

On Saturday, April 8, the Guardian published an article revealing that Dr. Paul Burton, the Chief Medical Officer for Moderna, said there will be a “highly effective” vaccine against the leading causes of death in the US in the next few years. He believes the treatments “will save many hundreds of thousands, if not millions of lives” and will be “personalized” to each individual.

Burton explained that this technology was rapidly accelerated by recent vaccine developments in 2019 and 2020. Moderna’s new vaccines will use biopsies from cancer sufferers to create patient-specific vaccines. Messenger RNA (mRNA) technology will identify mutations and instruct the recipient’s immune system to destroy those cancer cells. The Moderna leader also emphasized that the technology can “identify the genetic cause of a disease and, with relative simplicity, go and edit that out.”

Moderna is already in the late stages of its mRNA vaccine development for RSV, a harsh infection common in winter that is especially serious for newborns and older people. In January, the major medical firm shared its vaccine success rate of 83.7% for preventing RSV cough and fever in people over the age of 60. Due to this promising data, the FDA is designating it as a breakthrough therapy, allowing the agency to expedite its regulatory review process.

All of these new projects show that vaccine technology and development, in general, is speeding up, opening up new opportunities for companies to attempt to cure and even prevent specific diseases.

Copyright 2023,